Historical Stock Price
SGEN historical stock prices picture
Seagen (SGEN) has the following price history information. Looking back at SGEN historical stock prices for the last five trading days, on December 07, 2023, SGEN opened at $216.00, traded as high as $219.43 and as low as $215.93, and closed at $218.33. Trading volume was a total of 2.00M shares. On December 08, 2023, SGEN opened at $219.00, traded as high as $219.76 and as low as $218.18, and closed at $218.98. Trading volume was a total of 1.18M shares. On December 11, 2023, SGEN opened at $220.00, traded as high as $221.72 and as low as $219.00, and closed at $221.60. Trading volume was a total of 2.12M shares. On December 12, 2023, SGEN opened at $228.86, traded as high as $228.94 and as low as $228.81, and closed at $228.90. Trading volume was a total of 12.26M shares. On December 13, 2023, SGEN opened at $228.93, traded as high as $228.96 and as low as $228.74, and closed at $228.74. Trading volume was a total of 20.08M shares.

SGEN Historical Stock Prices By Date:

SGEN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Seagen shares, starting with a $10,000 purchase of SGEN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 12/13/2023
Start price/share: $46.79
End price/share: $228.74
Dividends collected/share: $0.00
Total return: 388.87%
Average Annual Total Return: 17.76%
Starting investment: $10,000.00
Ending investment: $48,883.80
Years: 9.71
Date Open High Low Close Volume
12/07/2023 $216.00 $219.43 $215.93 $218.33 2.00M
12/08/2023 $219.00 $219.76 $218.18 $218.98 1.18M
12/11/2023 $220.00 $221.72 $219.00 $221.60 2.12M
12/12/2023 $228.86 $228.94 $228.81 $228.90 12.26M
12/13/2023 $228.93 $228.96 $228.74 $228.74 20.08M
Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TUKYSA®, or tucatinib, for the treatment of certain metastatic HER2-positive breast and colorectal cancers, and TIVDAK®, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
Date Close
12/07/2023$218.33
12/08/2023$218.98
12/11/2023$221.60
12/12/2023$228.90
12/13/2023$228.74
SGEN is categorized under the Healthcare sector; below are some other companies in the same sector:

SGMO Historical Stock Prices
SGNL Historical Stock Prices
SGNT Historical Stock Prices
SGRY Historical Stock Prices
SGYP Historical Stock Prices
SHPG Historical Stock Prices
SHS Historical Stock Prices
SIEN Historical Stock Prices
SIGA Historical Stock Prices
SIGAQ Historical Stock Prices

Also explore: SGEN shares outstanding history

Email EnvelopeFree SGEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


SGEN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.